Jump to content

Philip Felgner

From Wikipedia, the free encyclopedia
Philip Felgner
Born
Philip Louis Felgner

(1950-02-07) 7 February 1950 (age 74)
Frankenmuth, Michigan, United States
Alma materMichigan State University
Scientific career
Fields

Philip Louis Felgner (born 7 February 1950) is an American biochemists and immunologists, specialized in lipofection technology and genetics. He is one of the developers of the vaccine against the SARS-CoV-2 virus, responsible for COVID-19 pandemic.

In 1972, he graduated in biochemistry from the Michigan State University, earning his master's degree in 1975 and his Ph.D. in 1978. He did postdoctoral work at the University of Virginia.[1]

In 2021, he was awarded the Princess of Asturias Awards for Technical and Scientific Research along Katalin Karikó, Drew Weissman, Uğur Şahin, Özlem Türeci, Derrick Rossi, and Sarah Gilbert.[2]

References[edit]

  1. ^ Philip L. Felgner UCI profile
  2. ^ "Katalin Karikó, Drew Weissman, Philip Felgner, Uğur Şahin, Özlem Türeci, Derrick Rossi, and Sarah Gilbert, Princess of Asturias Award for Technical and Scientific Research 2021". Princess of Asturias Foundation. 23 June 2021.


Stub icon

This biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Philip_Felgner&oldid=1227696289"